Sun Pharmaceutical Industries Ltd 2024 AR2
The report highlights Sun Pharmaceutical Industries Limited's performance for the fiscal year 2023-24, marking its 40th anniversary. The company achieved a consolidated revenue growth of 10.4% to reach INR 478 billion, driven by its expanding Global Specialty business, which contributed 18% to global turnover. Sun Pharma advanced its specialty pipeline with six candidates in clinical trials and expanded its field force in India and emerging markets. On the sustainability front, the company reduced its absolute Scope 1 and Scope 2 carbon emissions by 21.85% compared to the 2020 baseline, with renewable energy now accounting for 45.23% of its energy mix.
Company: Sun Pharmaceutical Industries Ltd
Sector: Manufacturing
Country: India
Year: 2024
Type: AR2
Pages: 312
Sun Pharmaceutical Industries Ltd
The report highlights Sun Pharmaceutical Industries Limited's performance for the fiscal year 2023-24, marking its 40th anniversary. The company achieved a consolidated revenue growth of 10.4% to reach INR 478 billion, driven by its expanding Global Specialty business, which contributed 18% to global turnover. Sun Pharma advanced its specialty pipeline with six candidates in clinical trials and expanded its field force in India and emerging markets. On the sustainability front, the company reduced its absolute Scope 1 and Scope 2 carbon emissions by 21.85% compared to the 2020 baseline, with renewable energy now accounting for 45.23% of its energy mix.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 1, 2023 - Mar 31, 2024
Fiscal Year
2024
Published
May 22, 2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees